www.BuyersGuideChem.com - the directory of chemicals and chemical suppliers. The search engine opens a large data base and offers new supply sources
Welcome About BGC Terms of Use MSDS Banner Adverts Statistics Impressum Sitemap
BGC > CAS Search > 503612-47-3
english deutsch español

Suppliers for CAS

503612-47-3



 

Properties

CAS   503612-47-3 
Formula   C25H25N5O4 

Structure

18 Registered suppliers


Amadis Chemical Company Limited P.R.China
H&Z Industry Co.,Ltd P.R.China

More details are to be found here
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd) P.R.China

More details are to be found here
Capot Chemical Co., Ltd. P.R.China
Leap Chem Co., Ltd P.R.China
Regent Science Industry Limited P.R.China
Molecular Formula: C25H25N5O4
Molecular Weight: 459.504
More details are to be found here
Shanghai Haoyuan Chemexpress Co., Ltd. P.R.China
Wuhan PharmChem Co., LTD. P.R.China
Aea.ltd P.R.China
EINECS :639-684-6
Molecular formula :C25H25N5O4
Hangzhou Zhongqi Chem Co., Ltd P.R.China
EINECS :639-684-6
Molecular formula :C25H25N5O4
Hangzhou Lingrui Chemical Co., Ltd. P.R.China
EINECS :639-684-6
Molecular formula :C25H25N5O4
BOC Sciences USA
Shandong SanYoung Industry Co., Ltd P.R.China
Description :
Apixaban (INN, trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation. It is a direct factor Xa inhibitor. Apixaban has been available in Europe since May 2011. The drug was developed in a joint venture by Pfizer and Bristol-Myers Squibb.
  • Molecular Weight :459.506
  • Boiling Point :770.5±60.0 °C at 760 mmHg
  • Purity :0.98
Molecular Formula :
C25H25N5O4
Canonical SMILES :
COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N
InChI :
InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)
InChIKey :
QNZCBYKSOIHPEH-UHFFFAOYSA-N
Solubility :
0.11mg/mL
Appearance :
White powder
Application :
Factor Xa Inhibitors
Synonyms :
BMS-562247-01; BMS 562247-01; BMS562247-01; brand name: Eliquis
More details are to be found here
AK Scientific, Inc. USA
Description :
Apixaban (INN, trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation. It is a direct factor Xa inhibitor. Apixaban has been available in Europe since May 2011. The drug was developed in a joint venture by Pfizer and Bristol-Myers Squibb.
  • Molecular Weight :459.506
  • Boiling Point :770.5±60.0 °C at 760 mmHg
  • Purity :0.98
Molecular Formula :
C25H25N5O4
Canonical SMILES :
COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N
InChI :
InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)
InChIKey :
QNZCBYKSOIHPEH-UHFFFAOYSA-N
Solubility :
0.11mg/mL
Appearance :
White powder
Application :
Factor Xa Inhibitors
Synonyms :
BMS-562247-01; BMS 562247-01; BMS562247-01; brand name: Eliquis
More details are to be found here
Chemos GmbH & Co. KG Germany
Description :
Apixaban (INN, trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation. It is a direct factor Xa inhibitor. Apixaban has been available in Europe since May 2011. The drug was developed in a joint venture by Pfizer and Bristol-Myers Squibb.
  • Molecular Weight :459.506
  • Boiling Point :770.5±60.0 °C at 760 mmHg
  • Purity :0.98
Molecular Formula :
C25H25N5O4
Canonical SMILES :
COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N
InChI :
InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)
InChIKey :
QNZCBYKSOIHPEH-UHFFFAOYSA-N
Solubility :
0.11mg/mL
Appearance :
White powder
Application :
Factor Xa Inhibitors
Synonyms :
BMS-562247-01; BMS 562247-01; BMS562247-01; brand name: Eliquis
More details are to be found here
BuGuCh & Partners Germany
Description :
Apixaban (INN, trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation. It is a direct factor Xa inhibitor. Apixaban has been available in Europe since May 2011. The drug was developed in a joint venture by Pfizer and Bristol-Myers Squibb.
  • Molecular Weight :459.506
  • Boiling Point :770.5±60.0 °C at 760 mmHg
  • Purity :0.98
Molecular Formula :
C25H25N5O4
Canonical SMILES :
COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N
InChI :
InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)
InChIKey :
QNZCBYKSOIHPEH-UHFFFAOYSA-N
Solubility :
0.11mg/mL
Appearance :
White powder
Application :
Factor Xa Inhibitors
Synonyms :
BMS-562247-01; BMS 562247-01; BMS562247-01; brand name: Eliquis
More details are to be found here
CM Fine Chemicals Switzerland
Description :
Apixaban (INN, trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation. It is a direct factor Xa inhibitor. Apixaban has been available in Europe since May 2011. The drug was developed in a joint venture by Pfizer and Bristol-Myers Squibb.
  • Molecular Weight :459.506
  • Boiling Point :770.5±60.0 °C at 760 mmHg
  • Purity :0.98
Molecular Formula :
C25H25N5O4
Canonical SMILES :
COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N
InChI :
InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)
InChIKey :
QNZCBYKSOIHPEH-UHFFFAOYSA-N
Solubility :
0.11mg/mL
Appearance :
White powder
Application :
Factor Xa Inhibitors
Synonyms :
BMS-562247-01; BMS 562247-01; BMS562247-01; brand name: Eliquis
More details are to be found here
Santa Cruz Biotechnology, Inc. USA
Description :
Apixaban (INN, trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation. It is a direct factor Xa inhibitor. Apixaban has been available in Europe since May 2011. The drug was developed in a joint venture by Pfizer and Bristol-Myers Squibb.
  • Molecular Weight :459.506
  • Boiling Point :770.5±60.0 °C at 760 mmHg
  • Purity :0.98
Molecular Formula :
C25H25N5O4
Canonical SMILES :
COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N
InChI :
InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)
InChIKey :
QNZCBYKSOIHPEH-UHFFFAOYSA-N
Solubility :
0.11mg/mL
Appearance :
White powder
Application :
Factor Xa Inhibitors
Synonyms :
BMS-562247-01; BMS 562247-01; BMS562247-01; brand name: Eliquis
More details are to be found here

Detailed information on the suppliers of
© Copyright 1996 to 2024 by Netvertise GmbH. All rights reserved